Pharmaceutical Contract Development and Manufacturing Market Overview:
The Pharmaceutical Contract Development and Manufacturing Market are projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also expected to offer market growth opportunities in the coming years.
This study involved four major activities in estimating the current size of the pharmaceutical contract development and manufacturing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Request For Sample:
COVID-19 impact on the pharmaceutical contract development and manufacturing market
Due to the Covid-19 pandemic, companies have scaled up R&D and manufacturing efforts to develop and distribute vaccines and drugs against the SARS-CoV-2 virus. Vaccine-related research activities in pharmaceutical & biotechnological companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. To expedite the R&D and manufacturing process, many pharmaceutical and biotechnology companies teamed up with CROs and CDMOs through long-term agreements, partnerships, and collaborations across the globe.
Download PDF Brochure:
Pharmaceutical Contract Development and Manufacturing Market, by Service
Pharmaceutical Manufacturing Services
Pharmaceutical API Manufacturing Services
Pharmaceutical FDF Manufacturing Services
Parenteral/injectable manufacturing services
Tablet manufacturing services
Capsule manufacturing services
Oral liquid manufacturing services
Semi-solid manufacturing services
Other formulations manufacturing services
Drug Development Services
Biologics Manufacturing Services
Biologics API manufacturing services
Biologics FDF manufacturing services
Pharmaceutical Contract Development and Manufacturing Market, by End User
Big Pharmaceutical Companies
Small & Medium-Sized Pharmaceutical Companies
Generic Pharmaceutical Companies
Other End Users
Get Detailed Information:
Key players in the pharmaceutical contract development and manufacturing market include Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd. (Switzerland), Recipharm AB (Sweden), AbbVie Inc. (US), Aenova Group (Germany), Almac Group (UK), and Siegfried Holding AG (Switzerland)
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 full-time analysts and SMEs at MarketsandMarkets™ are tracking global high-growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify the most important customers, write “Attack, avoid and defend” strategies, and identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high-growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge store” connects over 200,000 markets and entire value chains for a deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062